The Royal Australian College of GPs (RACGP) has called on the Western Australian Government to listen to the calls of families across the state and ...
Australia has a successful adolescent immunization program, routinely achieving high vaccine coverage for teenagers.
Australia has a successful adolescent immunisation program, routinely achieving high vaccine coverage for teenagers.Authors Archana Koirala ...
The global vaccine market accounted for $32,463 million in 2019 and is expected to reach $54,168 million by 2027, registering a CAGR of 6.6% from 2020 to 2027. It is estimated that vaccine market is ...
The value of carriage studies in providing additional information in relation to vaccine effects on meningococcal population biology has also been demonstrated. The MCC experience cannot be ...
Though GSK is definitely not the best large-cap drugmaker to have in one's portfolio, we believe there is potential for its ...
The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.
The Pharmaceutical Healthcare Association of the Philippines (PHAP) said it is supporting the routine and catch-up ...
“In South Australia, under national and state funded programs, the meningococcal B vaccine is available and free for infants at six weeks, four months, and 12 months and for adolescents in Year 10.
Parents or guardians will be given one month to update their child’s immunization record with OPH before a second notice is ...
The US Food and Drug Administration (FDA) has accepted a submission from GSK to review a new indication of Nucala ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback